Sanofi-Aventis U.S. LLC et al v. Mylan Laboratories Limited > Summary
Court Case Number 1:20-cv-00761
Filing Date Jun 5, 2020
Termination Date Sep 8, 2021
Court Delaware District Court
Status Dismissed - Settled
Appeal2023-2264
JudgesRichard G. Andrews
Defendant
Plaintiff Attorneys
13Sanofi
Attorney Name: William E. Solander
Venable
Sanofi
Attorney Name: Daniel J. Minion
Venable
Sanofi
Attorney Name: Whitney M. Howard
Venable
Sanofi
Attorney Name: Michael S. Scerbo
Venable
Sanofi
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Sanofi
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
SANOFI MATURE IP
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
SANOFI MATURE IP
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
SANOFI MATURE IP
Attorney Name: Whitney M. Howard
Venable
SANOFI MATURE IP
Attorney Name: Daniel J. Minion
Venable
SANOFI MATURE IP
Attorney Name: Michael S. Scerbo
Venable
SANOFI MATURE IP
Attorney Name: William E. Solander
Venable
Defendant Attorneys
6Viatris Inc.
Attorney Name: Wendy L. Devine
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Kristina M. Hanson
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: David E. Moore
Potter Anderson & Corroon
Viatris Inc.
Attorney Name: Bindu A. G. Palapura
Potter Anderson & Corroon
Viatris Inc.
Attorney Name: George E. Powell III
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Matthew R. Reed
Wilson Sonsini Goodrich & Rosati
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10716777 | Antitumoral use of cabazitaxel | Jul 21, 2020 |
| 10583110 | Antitumoral use of cabazitaxel | Mar 10, 2020 |
| 08927592 | Antitumoral use of cabazitaxel | Jan 6, 2015 |
| 05847170 | Taxoids, their preparation and pharmaceutical compositions containing them | Dec 8, 1998 |
